10-QPeriod: Q2 FY2008

Elevance Health, Inc. Quarterly Report for Q2 Ended Jun 30, 2008

Filed July 23, 2008For Securities:ELV

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) reported mixed financial results for the second quarter of 2008. While total operating revenue increased by 3% year-over-year to $15.5 billion, driven by premium rate increases and growth in Medicare Advantage, net income declined by 10% to $750.5 million. This decline was primarily attributed to higher medical costs and less favorable prior year reserve development. Diluted earnings per share (EPS) saw a slight increase of 7% to $1.44, benefiting from a significant reduction in outstanding shares due to the company's aggressive share repurchase program. Key financial pressures during the quarter included rising benefit expenses, which increased by 5% driven by higher medical costs in the Medicare Advantage segment and the Local Group fully-insured business. The company also experienced a notable decrease in operating cash flow compared to the prior year, largely due to timing of payments and increased receivables. Despite these challenges, the company continues to focus on cost management initiatives and strategic pricing and benefit design changes to mitigate medical cost trends. The substantial ongoing share repurchase program remains a key driver of EPS growth.

Financial Highlights

27 data points
Beta

Revenue

$15.67B

Net Income

$750.50M

4.8% Net Margin

EPS (Diluted)

$1.44

Cash & Equivalents

$2.27B

Free Cash Flow

$1.00B

Financial Statements
Beta
Revenue$15.67B
SG&A Expenses$2.22B
Interest Expense$116.50M
Net Income$750.50M
EPS (Basic)$1.44
EPS (Diluted)$1.44

Key Highlights

  • 1Total operating revenue increased 3% to $15.5 billion, driven by premium rate increases and Medicare Advantage growth.
  • 2Net income decreased 10% to $750.5 million, impacted by higher benefit expenses and medical costs.
  • 3Diluted EPS increased 7% to $1.44, aided by a substantial reduction in outstanding shares from share repurchases.
  • 4Benefit expense rose 5% to $12.0 billion, mainly due to higher medical costs in Medicare Advantage and adverse prior year reserve development.
  • 5Operating cash flow significantly decreased to $1.1 billion for the six months ended June 30, 2008, down from $2.7 billion in the prior year period.
  • 6The company repurchased approximately 46.5 million shares for $2.875 billion during the first six months of 2008.
  • 7Total assets decreased to $50.98 billion from $52.06 billion at the end of the previous year.

Frequently Asked Questions

Operating revenue increased primarily due to premium rate increases across all medical lines of business, growth in the Medicare Advantage business, and increased reimbursement in the Federal Employee Program (FEP). These were partially offset by the loss of a New York State prescription drug contract and declines in fully-insured membership.

Net income decreased primarily due to higher benefit expenses, which were driven by overall higher medical costs, particularly in the Medicare Advantage segment, and less favorable prior year reserve development. These increased costs outpaced the revenue growth.

The company repurchased approximately 46.5 million shares for $2.875 billion in the first six months of 2008. This significant reduction in the number of outstanding shares directly contributed to the 7% increase in diluted earnings per share, despite the decline in net income.

The company is facing challenges with rising medical costs, particularly in the Medicare Advantage business, attributed to higher utilization and adverse selection related to benefit design. They are implementing medical management initiatives and planning pricing and benefit design changes to address these issues.